Steris PLC (NYSE:STE) shares hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $137.27 and last traded at $135.80, with a volume of 703500 shares changing hands. The stock had previously closed at $134.76.

A number of research analysts recently issued reports on STE shares. JMP Securities reiterated a “buy” rating and issued a $135.00 price objective on shares of Steris in a report on Thursday, February 14th. Stephens reiterated a “buy” rating and issued a $135.00 price objective on shares of Steris in a report on Thursday, February 14th. Zacks Investment Research lowered shares of Steris from a “hold” rating to a “sell” rating in a report on Wednesday, April 17th. Finally, KeyCorp raised their price objective on shares of Steris from $135.00 to $138.00 and gave the company an “overweight” rating in a report on Wednesday, May 15th. Five analysts have rated the stock with a buy rating, Steris has a consensus rating of “Buy” and an average target price of $145.20.

The firm has a market cap of $11.57 billion, a PE ratio of 27.77 and a beta of 1.06. The company has a current ratio of 2.27, a quick ratio of 1.99 and a debt-to-equity ratio of 0.37.

Steris (NYSE:STE) last issued its quarterly earnings data on Monday, May 13th. The medical equipment provider reported $1.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.44 by $0.09. The business had revenue of $768.00 million during the quarter, compared to analyst estimates of $738.87 million. Steris had a net margin of 10.93% and a return on equity of 13.34%. The firm’s quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter last year, the business earned $1.24 EPS. Equities analysts expect that Steris PLC will post 5.38 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Wednesday, June 12th will be given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.00%. The ex-dividend date of this dividend is Tuesday, June 11th. Steris’s dividend payout ratio is presently 27.81%.

In other Steris news, CEO Walter M. Rosebrough, Jr. sold 50,000 shares of the stock in a transaction that occurred on Thursday, March 21st. The shares were sold at an average price of $125.00, for a total transaction of $6,250,000.00. Following the completion of the sale, the chief executive officer now owns 98,895 shares of the company’s stock, valued at approximately $12,361,875. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jacqueline B. Kosecoff sold 3,609 shares of the stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $132.22, for a total transaction of $477,181.98. The disclosure for this sale can be found here. Insiders have sold a total of 57,218 shares of company stock valued at $7,166,722 in the last three months. Insiders own 2.38% of the company’s stock.

Large investors have recently added to or reduced their stakes in the business. Pinebridge Investments L.P. acquired a new stake in Steris during the 1st quarter valued at approximately $50,000. Rockefeller Capital Management L.P. acquired a new stake in Steris during the 1st quarter valued at approximately $54,000. Advisory Services Network LLC increased its position in Steris by 26.0% during the 4th quarter. Advisory Services Network LLC now owns 427 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 88 shares during the period. Executive Wealth Management LLC acquired a new stake in Steris during the 4th quarter valued at approximately $47,000. Finally, Enlightenment Research LLC acquired a new stake in Steris during the 4th quarter valued at approximately $53,000. 86.81% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This article was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another site, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://www.thecerbatgem.com/2019/05/22/steris-ste-sets-new-1-year-high-at-137-27.html.

Steris Company Profile (NYSE:STE)

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Featured Article: Portfolio Manager

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.